Lifestyle
- Regular exercise
- Stress management
- Adequate sleep
Blutsenkungsgeschwindigkeit · ESR · Erythrozyten-Sedimentationsrate · Erythrocyte Sedimentation Rate
ESR measures the rate at which erythrocytes (red blood cells) settle at the bottom of a test tube over an hour, indicating the presence of inflammation.
Reference ranges can vary based on age and sex. Typically, women have slightly higher ESR values than men.
The erythrocyte sedimentation rate (ESR), also known as Blutsenkungsgeschwindigkeit (BSG) or Erythrozyten-Sedimentationsrate, is a blood test that measures the rate at which red blood cells sediment in a period of one hour. It is a non-specific marker of inflammation and is often used in conjunction with other tests to assess inflammatory conditions. Clinically, ESR is used to detect inflammation associated with conditions such as infections, cancers, and autoimmune diseases. It is particularly useful in diagnosing and monitoring diseases like rheumatoid arthritis and inflammatory bowel disease. Researchers have found that ESR can reflect disease activity, as seen in conditions like rheumatoid arthritis, where elevated levels correlate with disease severity. In the context of athletic performance, biohacking, or longevity, ESR is not directly related to performance metrics but may be used to monitor systemic inflammation, which can impact recovery and overall health. It is important to note that ESR can be influenced by various factors, including age, sex, and certain medications. Time of day and fasting status do not significantly affect ESR, but it should be interpreted alongside other clinical assessments and laboratory tests to provide a comprehensive view of an individual's health status.
Klinische Bedeutung
Elevated ESR values typically indicate the presence of inflammation due to conditions such as infections, autoimmune diseases, or cancers. Low ESR values are generally not clinically significant but can occur in conditions like polycythemia or extreme leukocytosis.
Progressively rising ESR values suggest increasing inflammation, warranting further investigation and possibly more frequent monitoring.
Decreasing ESR values may indicate a reduction in inflammation or response to treatment.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any new supplement regimen, especially if you have underlying health conditions.
Testing Frequency
As needed for monitoring inflammatory conditions or as directed by a healthcare provider.
Correlated with
Current research suggests that the reference ranges and optimal targets for BSG (CD147) in various cancers remain poorly defined, with confounding factors such as co-expressed biomarkers like PPIA (Cyclophilin A) complicating interpretation. Emerging research directions include exploring the therapeutic potential of targeting the CypA/CD147 interaction in cancer treatment. However, clinical questions remain unanswered regarding the specific mechanisms by which BSG influences cancer progression and its role as a prognostic indicator across different tumor types.
718
Total Citations
11
Human/RCT
5.5
Avg. Influence
2025
Latest
Bray Christopher, et al. · WMJ : official publication of the State Medical Society of Wisconsin · 2016
This review examined the use of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as markers of systemic inflammation. Researchers found that these tests should be interpreted alongside clinical history due to their lack of specificity and sensitivity. Discrepancies between ESR and CRP readings were noted, particularly in chronic inflammatory diseases.
Key findings
Researchers reviewed current biomarkers for inflammatory bowel disease (IBD), highlighting the challenges in diagnosis and monitoring. They noted that while CRP and ESR are commonly used, they are not ideal, and ongoing research aims to identify better biomarkers for IBD.
Inciarte-Mundo José, et al. · Frontiers in immunology · 2022
This study focused on calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis (RA). Researchers found that higher calprotectin levels correlate better with disease activity than CRP or ESR. Additionally, calprotectin levels decreased after treatment, indicating its potential as a biomarker for monitoring RA.
Key findings
Researchers investigated the interaction between Cyclophilin A and CD147 in cancer progression. They found that overexpression of the genes encoding these proteins was associated with poor prognosis in various cancers, indicating their potential as therapeutic targets.
This clinical investigation assessed the anti-inflammatory effects of remimazolam, an anesthetic agent. Researchers found that remimazolam exhibited antioxidant properties and resulted in lower postoperative CRP levels compared to dexmedetomidine.
This systematic review focused on the role of elevated IgG4 in rheumatoid arthritis (RA). Researchers found a significant correlation between IgG4 levels and disease activity, as well as a decline in IgG4 levels with disease-modifying anti-rheumatic drug treatment, suggesting its potential as a biomarker for RA.
This systematic review identified that elevated ESR or CRP levels are associated with systemic involvement in Degos disease. Researchers found that these markers could help predict the prognosis of patients with malignant forms of the disease.
This study assessed ocular involvement in Kawasaki disease and its relationship with other clinical and laboratory findings. Researchers found that higher neutrophil counts and CRP levels were associated with uveitis in these patients, indicating a potential link between ocular symptoms and inflammation.
Researchers explored the role of laboratory tests in diagnosing systemic vasculitis. They highlighted that while ESR and CRP are useful, they are nonspecific and cannot differentiate between disease activity and other inflammatory conditions.
This study investigated the expression of lncRNA NEAT1 in spinal tuberculosis patients. Researchers found that NEAT1 levels correlated with clinical characteristics and inflammatory markers, suggesting its potential as a prognostic biomarker.
Research publications about BSG over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer